> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# SterRx Recalls 3 Sodium Bicarbonate Lots
- URL: https://www.fdaweb.com/sterrx-recalls-3-sodium-bicarbonate-lots/
- Published: 2021-08-11T12:00:00.000Z
- Updated: 2026-09-14T17:10:15.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5149913

SterRx has recalled three lots of sodium bicarbonate in 5% dextrose injection 150mEq per 1,000 mL due to waterborne microbial contamination. Intravenous administration of contaminated product “could result in site specific infections as well as serious systemic infections which may be life-threatening,” a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sterrx-llc-issues-voluntary-nationwide-recall-sodium-bicarbonate-5-dextrose-injection-150meq-1000-ml?ref=fdaweb.com) says. To date, SterRx says it has not received reports of any adverse events associated with the issue. Sodium bicarbonate injection is indicated for treating high potassium, irregular heartbeat, metabolic acidosis related to severe issues.